Zdrowie i gospodarka · 21/05/1998

Determination That Carbinoxamine Maleate 4-Milligram Immediate- Release Tablets Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

The Food and Drug Administration (FDA) has determined that carbinoxamine maleate (Clistin ) 4-milligram (mg) immediate- release tablets were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDA's) for carbinoxamine maleate 4-mg immediate-release tablets.